A new study is highlighting significant health inequities between New Zealanders living with multiple sclerosis and their Australian counterparts.
The study found that Australians with the auto-immune disease - three-quarters of them women - enjoy nearly double the rate of access to MS drug treatments than do their Kiwi counterparts.
What's more, the Aussies surveyed tend to get their treatments a lot earlier. Mutiple Sclerosis NZ will be using the findings to argue for Pharmac to bridge the trans-Tasman gap.
Its president Neil Woodhams spoke to Susie Ferguson.
